Procter & Gamble (PG) Stock Today: JPMorgan Cuts Price Target to $157 as Wall Street Weighs 2026 Catalysts

Procter & Gamble (PG) Stock Today: JPMorgan Cuts Price Target to $157 as Wall Street Weighs 2026 Catalysts

December 18, 2025 — Procter & Gamble (NYSE: PG) shares traded lower on Thursday as investors digested fresh sell-side research updates and recalibrated expectations for 2026. PG was last seen around $145.5, down roughly 1.6% on the session, after closing $147.81 on December 17. MarketBeat+1 The day’s PG-specific headline flow is less about a single operational surprise and more about where analysts think “fair value” sits after a difficult 2025 for many defensive consumer names—and ahead of several clear catalysts for P&G in early 2026, including a CEO transition on January 1 and an anticipated earnings call on January 22.
Home Depot Stock (NYSE:HD) News Today (Dec. 18, 2025): Dividend Day, 2026 Outlook, and Fresh Analyst Forecasts

Home Depot Stock (NYSE:HD) News Today (Dec. 18, 2025): Dividend Day, 2026 Outlook, and Fresh Analyst Forecasts

Home Depot (NYSE: HD) is back in focus on December 18, 2025, with investors weighing a mix of market-driven momentum, newer FY2026 growth targets, and a steady shareholder-return story anchored by today’s dividend payment. In afternoon trading, the stock hovered around $356 per share, down modestly versus the prior close, keeping it in the lower half of its 52‑week range after a volatile stretch for housing-linked names. Investing.com The day’s tape also shows why HD keeps showing up in market headlines: early gains in Home Depot were among the notable contributors lifting the price-weighted Dow during the session. MarketWatch Below
Fermi Inc (FRMI) Stock on Dec. 18, 2025: Amazon-Tenant Claims Clash With Company Denial as Analysts Recut Targets After Project Matador Setback

Fermi Inc (FRMI) Stock on Dec. 18, 2025: Amazon-Tenant Claims Clash With Company Denial as Analysts Recut Targets After Project Matador Setback

Fermi Inc (NASDAQ & LSE: FRMI) is having the kind of week that turns a normal stock chart into modern art: sharp gaps, headline-driven swings, and investors trying to separate what’s confirmed from what’s merely energetic speculation. On December 18, 2025, FRMI closed at $8.34, down 7.98% on the day, after opening near $9.31 and trading as high as $9.33 and as low as $8.27—with roughly 7.52 million shares changing hands. Investing.com That move sits on top of an even bigger story: Fermi’s “first tenant” financing arrangement for its flagship Project Matador in Texas was terminated last week, triggering a
Bloom Energy Stock (NYSE:BE) Rebounds on Fuel-Cell Rally and Cooling Inflation: Dec. 18 News, Analyst Forecasts, and What Investors Are Watching

Bloom Energy Stock (NYSE:BE) Rebounds on Fuel-Cell Rally and Cooling Inflation: Dec. 18 News, Analyst Forecasts, and What Investors Are Watching

Dec. 18, 2025 — Bloom Energy Corporation’s stock swung sharply again Thursday as investors weighed a powerful mix of macro tailwinds, fuel-cell sector momentum, and still-heated debate over valuation. Shares finished Dec. 18 at $81.63, up from $76.97 the prior session—an advance of roughly 6% day over day after a turbulent week for AI-linked and power-infrastructure names. Yahoo Finance+1 What happened to Bloom Energy stock on Dec. 18, 2025 Bloom Energy shares gapped up at the open and traded through a wide range before cooling into the close. According to historical pricing data, BE opened at $82.91, hit an intraday
Shopify Stock Jumps on Analyst Price-Target Upgrades and Cooling Inflation — What’s Next for SHOP Shares (Dec. 18, 2025)

Shopify Stock Jumps on Analyst Price-Target Upgrades and Cooling Inflation — What’s Next for SHOP Shares (Dec. 18, 2025)

Shopify Inc. shares rallied on Thursday, December 18, as a fresh wave of Wall Street price-target increases collided with a friendlier macro backdrop for growth stocks. Shopify’s U.S.-listed shares (NASDAQ: SHOP) were up 3.6% to $167.56 in mid-afternoon pricing (as of 2:16 p.m. ET, delayed), after touching an intraday high of $172.96. The move pushed the stock to within roughly 8% of its 52-week high. Shopify Investors Investors have two clear narratives to digest today: a cluster of bullish analyst updates that revived the “$200 target” conversation, and a cooler U.S. inflation print that strengthened hopes the Federal Reserve can
Qualcomm (QCOM) Stock News Today: Alphawave Semi Deal Closes Early, Dividend Paid, and 2026 Forecasts in Focus (Dec. 18, 2025)

Qualcomm (QCOM) Stock News Today: Alphawave Semi Deal Closes Early, Dividend Paid, and 2026 Forecasts in Focus (Dec. 18, 2025)

Qualcomm Incorporated (NASDAQ: QCOM) is back in the spotlight on Thursday, December 18, 2025, as investors digest two developments that matter to shareholders right now: the early close of Qualcomm’s Alphawave Semi acquisition and a cash dividend landing today—all while Wall Street keeps one eye on Qualcomm’s next earnings checkpoint and its expanding AI narrative. The day’s headlines are not just about a completed transaction—they’re about what Qualcomm is trying to become in 2026: a company that still dominates premium Android silicon, but also pushes deeper into AI infrastructure, custom CPUs, and data center connectivity, where the prize is measured
Intuit (INTU) Stock News Today: Circle USDC Stablecoin Deal, TurboTax Push, and Fresh Wall Street Forecasts (Dec. 18, 2025)

Intuit (INTU) Stock News Today: Circle USDC Stablecoin Deal, TurboTax Push, and Fresh Wall Street Forecasts (Dec. 18, 2025)

Intuit Inc. (NASDAQ: INTU) is in focus on Thursday, December 18, 2025, after announcing a multi-year partnership with Circle Internet Group to bring USDC stablecoin capabilities into Intuit’s ecosystem—TurboTax, QuickBooks, and Credit Karma—while also launching a new consumer-facing tax-season campaign aimed at boosting engagement and refunds. Intuit Investors+1 Key takeaways for INTU stock on Dec. 18, 2025 INTU’s headline news on Dec. 18: Intuit partners with Circle to bring USDC stablecoins to TurboTax, QuickBooks, and Credit Karma Intuit said Thursday it has formed a multi-year strategic partnership with Circle to incorporate stablecoin technology (USDC) across Intuit’s financial platforms. The company
Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences Ltd. (NASDAQ: WVE) is back in the spotlight on December 18, 2025—not because of a brand-new press release, but because the stock is still digesting one of the most volatile biotech weeks of the year. In Thursday trading, WVE stock fell roughly mid-single digits, hovering in the mid-$15 range after closing around $16.34 the prior session, according to market data and widely circulated market recaps. StockAnalysis+1 That pullback matters because it comes right after a dramatic early-December surge tied to Wave’s obesity program—and immediately following a large equity financing that materially changes the company’s cash position and
Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stock slid sharply on Thursday, December 18, 2025, after a regulatory filing revealed a leadership transition involving the company’s Chief Medical and Development Officer. In trading, CRNX fell roughly 8% to around the mid‑$40s, with the day’s range stretching from the low‑$40s to the high‑$40s as investors digested the update. Investing.com For a biotech stock—especially one in the middle of a major product launch and multiple late‑stage trials—management continuity matters. But so do fundamentals: Crinetics is no longer “just” a clinical-stage story. It recently reached a pivotal milestone with its first FDA-approved product, and its
Adobe Stock (ADBE) News, Forecasts and Analyst Outlook for Dec. 18, 2025: Citi Raises Target, FY2026 Guidance, and a New AI Copyright Lawsuit

Adobe Stock (ADBE) News, Forecasts and Analyst Outlook for Dec. 18, 2025: Citi Raises Target, FY2026 Guidance, and a New AI Copyright Lawsuit

Adobe Inc. (NASDAQ: ADBE) stock is back in the spotlight on Thursday, Dec. 18, 2025, as investors balance three forces that have increasingly defined the company’s narrative in late 2025: (1) a solid earnings-and-guidance package that leans on subscription durability, (2) a fast-evolving generative AI strategy designed to defend (and expand) Adobe’s creative and marketing software moat, and (3) rising legal and competitive risk tied to how AI systems are trained and monetized. Shares were trading around $354 on Thursday, with the session’s range extending roughly from the low $350s to the high $350s. Below is a detailed roundup of
Carvana Stock (CVNA) News and Forecast: S&P 500 Inclusion, Analyst Targets, and the 2026 Setup (Dec. 18, 2025)

Carvana Stock (CVNA) News and Forecast: S&P 500 Inclusion, Analyst Targets, and the 2026 Setup (Dec. 18, 2025)

Carvana Co. shares (NYSE: CVNA) bounced higher on Thursday, Dec. 18, as investors looked past recent volatility and refocused on two powerful themes: the company’s imminent addition to the S&P 500 and Wall Street’s still-constructive outlook on Carvana’s post-turnaround earnings trajectory. CVNA was last trading around $463, up roughly 3.8% on the day, after opening near $449 and touching an intraday high near $464. The timing matters. Carvana is heading into the final stretch before it officially joins the S&P 500, a milestone that can reshape the shareholder base through index-tracking demand. Meanwhile, analysts and investors are debating a harder
UnitedHealth Group Stock (UNH) News Today, Dec. 18, 2025: Policy Risk, Optum Rx Changes, and Wall Street Forecasts

UnitedHealth Group Stock (UNH) News Today, Dec. 18, 2025: Policy Risk, Optum Rx Changes, and Wall Street Forecasts

UnitedHealth Group Incorporated (NYSE: UNH) stock is ending a volatile 2025 with fresh headline risk—and a handful of potentially meaningful catalysts—front and center on December 18, 2025. Shares traded around $326–$327 in midday trading, after moving between roughly $324.66 and $330.50 intraday. While UnitedHealth remains one of the most closely watched blue-chip healthcare names, 2025 has been defined by unusually wide investor debate about near-term earnings durability, regulatory risk, and the pace of normalization into 2026. By one Reuters-tracked measure, UNH’s year-to-date price return is roughly -32.6%—a drop that helps explain why even incremental “good news” headlines can move the

Stock Market Today

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

7 February 2026
Amazon shares fell Friday after the company announced a $200 billion AI infrastructure plan for 2026, exceeding analyst expectations and reviving investor concerns about profitability. Combined 2026 capex flagged by Amazon, Alphabet, Microsoft, and Meta now tops $630 billion. Nvidia, AMD, and Broadcom shares surged on the news, while software and data firms remained under pressure.
Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

7 February 2026
Nvidia surged 7.8% Friday, leading a chip stock rally that pushed the Dow above 50,000 for the first time. The PHLX semiconductor index gained 5.7% as Advanced Micro Devices rose 8.3% and Broadcom 7.1%. Amazon fell 5.6% after projecting $200 billion in 2026 capital spending. Investors weighed a $600 billion AI infrastructure outlay against sharp losses in software shares.
Go toTop